https://wikem.org/w/index.php?action=history&feed=atom&title=Template%3AAntibiotics_Ludwigs_Immunocompromised%2Fes
Template:Antibiotics Ludwigs Immunocompromised/es - Revision history
2026-04-19T01:55:20Z
Revision history for this page on the wiki
MediaWiki 1.38.2
https://wikem.org/w/index.php?title=Template:Antibiotics_Ludwigs_Immunocompromised/es&diff=383687&oldid=prev
FuzzyBot: Updating to match new version of source page
2026-01-23T08:29:44Z
<p>Updating to match new version of source page</p>
<table style="background-color: #fff; color: #202122;" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 08:29, 23 January 2026</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td>
<td colspan="2" class="diff-lineno">Line 1:</td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><noinclude><languages/></noinclude></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><noinclude><languages/></noinclude></div></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"><div lang="en" dir="ltr" class="mw-content-ltr"></del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>====<ins style="font-weight: bold; text-decoration: none;">Inmunocomprometido</ins><ref>Spitalnic SJ, Sucov A. Ludwig's angina: case report and review. J Emerg Med. 1995;13:499-503</ref>====</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>====<del style="font-weight: bold; text-decoration: none;">Immunocompromised</del><ref>Spitalnic SJ, Sucov A. Ludwig's angina: case report and review. J Emerg Med. 1995;13:499-503</ref>====</div></td><td colspan="2" class="diff-side-added"></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"></div></del></div></td><td colspan="2" class="diff-side-added"></td></tr>
<tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"><div lang="en" dir="ltr" class="mw-content-ltr"></del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefepime|Cefepime]] 2 g IV <ins style="font-weight: bold; text-decoration: none;">cada 12 horas </ins>+ [[Special:MyLanguage/Metronidazole|Metronidazole]] 500 mg IV <ins style="font-weight: bold; text-decoration: none;">cada 6 horas O</ins></div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefepime|Cefepime]] 2 g IV <del style="font-weight: bold; text-decoration: none;">q12 hrs </del>+ [[Special:MyLanguage/Metronidazole|Metronidazole]] 500 mg IV <del style="font-weight: bold; text-decoration: none;">q6 hrs OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Meropenem|Meropenem]] 1 g IV <ins style="font-weight: bold; text-decoration: none;">cada 8 horas O</ins></div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Meropenem|Meropenem]] 1 g IV <del style="font-weight: bold; text-decoration: none;">q8 hrs OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Imipenem/Cilastatin|Imipenem/Cilastatin]] 500mg (20mg/kg) IV <ins style="font-weight: bold; text-decoration: none;">cada 6 horas</ins></div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Imipenem/Cilastatin|Imipenem/Cilastatin]] 500mg (20mg/kg) IV <del style="font-weight: bold; text-decoration: none;">q6 hours</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Piperacillin-tazobactam|Piperacillin-tazobactam]] 4.5g (80mg/kg) IV <ins style="font-weight: bold; text-decoration: none;">cada 6 horas</ins></div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Piperacillin-tazobactam|Piperacillin-tazobactam]] 4.5g (80mg/kg) IV <del style="font-weight: bold; text-decoration: none;">q6 hours</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*<ins style="font-weight: bold; text-decoration: none;">Agregar </ins>[[Special:MyLanguage/Vancomycin|<ins style="font-weight: bold; text-decoration: none;">Vancomicina</ins>]] 15-20 mg/kg IV <ins style="font-weight: bold; text-decoration: none;">cada 8 horas </ins>(<ins style="font-weight: bold; text-decoration: none;">máximo </ins>2 g <ins style="font-weight: bold; text-decoration: none;">por dosis</ins>) <ins style="font-weight: bold; text-decoration: none;">si hay preocupación por factores de riesgo de </ins>MRSA</div></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*<del style="font-weight: bold; text-decoration: none;">Add </del>[[Special:MyLanguage/Vancomycin|<del style="font-weight: bold; text-decoration: none;">Vancomycin</del>]] 15-20 mg/kg IV <del style="font-weight: bold; text-decoration: none;">q8 hrs </del>(<del style="font-weight: bold; text-decoration: none;">max </del>2 g <del style="font-weight: bold; text-decoration: none;">per dose</del>) <del style="font-weight: bold; text-decoration: none;">if concern for </del>MRSA <del style="font-weight: bold; text-decoration: none;">risk factors</del></div></td><td colspan="2" class="diff-side-added"></td></tr>
<tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;"></div></del></div></td><td colspan="2" class="diff-side-added"></td></tr>
</table>
FuzzyBot
https://wikem.org/w/index.php?title=Template:Antibiotics_Ludwigs_Immunocompromised/es&diff=383681&oldid=prev
Ostermayer: Created page with "Template:Antibiotics Ludwigs Immunocompromised"
2026-01-23T08:26:36Z
<p>Created page with "Template:Antibiotics Ludwigs Immunocompromised"</p>
<p><b>New page</b></p><div><noinclude><languages/></noinclude><br />
<br />
<div lang="en" dir="ltr" class="mw-content-ltr"><br />
====Immunocompromised<ref>Spitalnic SJ, Sucov A. Ludwig's angina: case report and review. J Emerg Med. 1995;13:499-503</ref>====<br />
</div><br />
<br />
<div lang="en" dir="ltr" class="mw-content-ltr"><br />
*[[Special:MyLanguage/Cefepime|Cefepime]] 2 g IV q12 hrs + [[Special:MyLanguage/Metronidazole|Metronidazole]] 500 mg IV q6 hrs OR<br />
*[[Special:MyLanguage/Meropenem|Meropenem]] 1 g IV q8 hrs OR<br />
*[[Special:MyLanguage/Imipenem/Cilastatin|Imipenem/Cilastatin]] 500mg (20mg/kg) IV q6 hours<br />
*[[Special:MyLanguage/Piperacillin-tazobactam|Piperacillin-tazobactam]] 4.5g (80mg/kg) IV q6 hours<br />
*Add [[Special:MyLanguage/Vancomycin|Vancomycin]] 15-20 mg/kg IV q8 hrs (max 2 g per dose) if concern for MRSA risk factors<br />
</div></div>
Ostermayer